Featured

The MACRA Final Rule: A 2017 Primer for Electrophysiologists

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) will make significant changes to how Medicare pays for physician services and will reshape the delivery of patient care. Please attend HRS’s first of two complimentary webinars to learn how MACRA’s Quality Payment Program will affect your billing and payments. 

Access this Activity

Cryptogenic Stroke: Diagnostics and Tools to Determine Root Cause

Now Available — Major Bleeding Complications in Cryptogenic Stroke - Case Study Three

This complimentary activity is jointly provided by the Heart Rhythm Society and National Stroke Association. The program will educate healthcare professionals on the connection between cryptogenic stroke and atrial fibrillation and identify cardiac monitoring as an effective tool in determining root cause.  

Learn more

New Learning Pathway

EP Ablation Technologies

The activity below contains a number of presentations by world experts describing the status of different novel ablation technologies. These include a wide selection of tools ranging from the recently developed contact force sensing, and rotor mapping and ablation, to novel and futuristic ablation technologies such as extra-corporeal non-invasive ablation using Carbon ion particle therapy. The information presented provide the reader with an up-to-date summary of these technologies and a preview on how the field will look like in next 5-10 years.

Access this Activity

Journal CME/HeartRhythm Journal: January 2017 Vol. 14, Issue 1: Metaiodobenzylguanidine (MIBG) Imaging in Patients with Atrial Fibrillation Undergoing Mapping and Ablation of Autonomic Ganglia

  • Description
  • Faculty
  • CME Information

The impact of ablation of ganglionated plexuses during ablation of AF on ventricular myocardial innervation is unknown. Previous animal studies have shown different electrophysiological outcomes of ventricular myocardial denervation following ablation of autonomic ganglia. A recent animal report demonstrated that the ligament of Marshall could represent a conduit between the left stellate ganglion and the ventricle. There have been no reports evaluating detailed GP mapping and ablation in the atria and potential effects on ventricular sympathetic myocardial innervation. Could the autonomic footprint left by atrial ablation be visualized in the ventricle? We performed I-123 metaiodobenzylguanidine (MIBG) imaging in 5 patients with  AF, comparing pre-ablation with early and late post-ablation imaging (ClinicalTrials.gov NCT02071680).

Robert Lemery, MD
Shlomo Ben-Haim, MD
Glenn Wells, PhD
Terrence D. Ruddy, MD


The Heart Rhythm Society designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™

EP Ablation Technologies

  • Description
  • Program
  • Faculty

The activity below contains a number of presentations by world experts describing the status of different novel ablation technologies. These include a wide selection of tools ranging from the recently developed contact force sensing, and rotor mapping and ablation, to novel and futuristic ablation technologies such as extra-corporeal non-invasive ablation using Carbon ion particle therapy. The information presented provide the reader with an up-to-date summary of these technologies and a preview on how the field will look like in next 5-10 years.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Biophysics for Electrophysiologists – duration total <84 minutes
  • Contact Force Sensing During AF Ablation - Technologies, Results and Impact on Clinical Outcomes –duration < 18 minutes
  • EP on Point:  Cryoballoon vs. RF Ablation for PVI – duration <22 minutes
  • AF Ablation Tools – duration <30 minutes
  • Debate - Paroxysmal AF Ablation: Use the Force or Ice it! – duration <45 minutes
  • Debate-Cryo vs. Fry-o – duration <45 minutes
  • New Tools and Approaches for AF Management – duration <50 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

David E. Haines, MD, FHRS 
Beaumont Health
Royal Oak, MI 

Gregory F. Michaud, MD, FHRS
Brigham and Women's Hospital
Boston, MA

Andre d'Avila, MD, PhD
Hospital Cardiologico
Florianopolis, Brazil

Boaz Avitall, MD, PhD, FHRS
University of Illinois
Chicago, IL

Moussa Mansour, MD
Massachusetts General Hospital
Institute for Heart, Vascular and Stroke Care
Boston, MA

Jason Andrade BSc, FRCPC
Vancouver General Hospital and University of British Columbia
Montreal Heart Institute and Université de Montreal

Karl-Heinz Kuck, MD, FHRS
Asklepios Klinik St. Georg
Hamburg, Germany

Ellen Hoffmann, MD
Heart Center Munich-Bogenhausen
Munich, Germany

Roland R. Tilz, MD
Asklepios Klinik St. Georg 
Hamburg, Germany

Richard J. Czosek, MD, CCDS
Cincinnati Children's Hospital
Cincinnati, OH

Peter S. Fischbach, MD, MA, CCDS
Sibley Heart Center
Atlanta, GA

Petr Neuzil, MD, PhD
Na Homolce Hospital
Prague, Czech Republic

Isabel V. Deisenhofer, MD
Deutsches Herzzentrum München
Munich, Germany

Douglas Packer, MD, FHRS 
Mayo Clinic
Rochester, MN

The MACRA Final Rule: A 2017 Primer for Electrophysiologists

  • Description
  • Learning Objectives
  • Faculty

This forty minute complimentary on-demand webinar, presented by Michael Gold, MD, FHRS and Robert Jasak, JD, will provide an overview of the new program as it is detailed in the final rule. If you have questions while you watch the webinar, you can emailyour questions to HRS at policy@hrsonline.org.

  • Understand the MACRA framework
  • Explain the differences between the Medicare fee-for-service and MACRA payment structures
  • Discuss MACRA’s implications for heart rhythm professionals
Faculty

Michael R. Gold, MD, PhD, FHRS
President, Heart Rhythm Society

Robert Jasak, JD
Vice-President
Coverage and Payment Policy
Hart Health Strategies, Inc.

Cryptogenic Stroke: Diagnostics and Tools to Determine Root Cause

  • Description
  • Learning Objectives
  • Faculty

Cryptogenic Stroke: Diagnostics and Tools to Determine Root Cause
Webinar Date: Oct. 26, 2016

This complimentary activity is jointly provided by the Heart Rhythm Society and National Stroke Association.

The program will educate healthcare professionals through a multi-platform case study based CME initiative, which will highlight the connection between cryptogenic stroke and atrial fibrillation, and identify cardiac monitoring as an effective tool in determining root cause.  The activity includes a 60 minute webinar and three subsequent Case Study activities designed to apply knowledge gained in viewing the enduring product.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this live activity for a maximum of 2.5 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity

Learning Objectives

Through participation in this activity, learners should be able to:

  • Explain the relationship between cryptogenic stroke and atrial fibrillation
  • Discuss different types of cardiac monitoring and define which patients might benefit
  • Identify points at which cardiac monitoring is appropriate during the course of treatment
  • Report greater confidence in recommending diagnostic tests to monitor and test for atrial fibrillation

Faculty

Gorelick picture

Philip B. Gorelick, MD, MPH, FACP
Professor, Translational Science & Molecular Medicine
Michigan State University College of Human Medicine
Medical Director, Mercy Health Hauenstein Neurosciences

Richards Picture

Mark Richards, MD, PhD, FACC, FHRS
Director, Arrhythmia Services Northwest Ohio Cardiology Consultants

HRS Roundtable: Managing Risk of Premature and Rapid Battery Depletion

  • Description
  • Learning Objectives
  • Faculty

On October 11, 2016, the U.S. Food and Drug Administration issued a safety communication alerting health care providers and patients about premature battery depletion in a subset of St. Jude Medical ICD and CRT-D devices.

During this 70 min on-demand webinar, Dr. Gold, Dr. Van Hare, Dr. Slotwiner from the HRS, Dr. Carlson from St Jude Medical, Dr. Selzman and Ms. Paulsen from the U.S. Food and Drug Administration answer the questions submitted during a HRS-hosted Twitter Chat held on October 24, 2016. Among the questions addressed are:

  • Are issues related to lithium clusters unique to the St Jude Medical ICDs and CRT- D manufactured between January 2010 and May 2015? Are you aware of other device models or manufacturers that are affected?
  • How frequently we should interrogate the patients that have existing device?
  • Should all affected patients be on remote monitoring?
  • Were measures taken after May 2015 to mitigate the problem of premature battery depletion?

For more information about this safety alert, please visit the Society’s Safety Alert Resource Center.

  • Explain the details of the safety alert.
  • Understand the implications for patients. 
  • Discuss and answer the questions that were submitted during the twitter chat. 

Michael R. Gold, MD, PhD, FHRS
President
Heart Rhythm Society

George F. Van Hare, MD, FHRS
President-Elect
Heart Rhythm Society

David J. Slotwiner, MD, FHRS
Chair, Health Policy Committee
Heart Rhythm Society

Mark D. Carlson, MD, MA
Chief Medical Officer and Vice President Global Clinical Affairs
St Jude Medical

Jessica Paulsen
Branch Chief
Implantable Electrophysiology Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Kimberly Selzman, MD, FHRS
Medical officer
Implantable Electrophysiology Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Ventricular Tachycardia Mapping and Ablation in Structural Heart Disease

  • Description
  • Presentations
  • Faculty

The ablation strategy for Ventricular Tachycardia (VT) varies greatly depending on the etiology of the VT.  This learning pathway begins with the common idiopathic and scar related VTs for routine ablation, highlighting critical basic concepts and techniques.   Next up, high level tips for the complex and rare  arrhythmias that many electrophysiologists will have minimal exposure in daily practice.  Completing the entire learning pathway will provide users with a broad base of experience and perspective to assist in providing quality care to VT patients

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations include:
•Anatomy of Substrate for VT in Structural Heart Disease – duration <16 minutes
•Entrainment Mapping for Scar-Related Ventricular Tachycardias – duration <26 minutes
•Epicardial Substrate Ablation of Ventricular Tachycardia in Late Myocarditis: Techniques & Outcomes – duration <20 minutes
•Anterior, Posterior Puncture And Needle-in-Needle Technique – duration <20 minutes
•Important Anatomical Landmarks of Epicardial Access – duration <20 minutes
•Curing the Brugada Syndrome with Epicardial Ablation: When and How – duration <15 minutes
•Conduction System Re-entry VT – duration <15 minutes
•VT Ablation in Patients with Cardiac Sarcoidosis – duration <15 minutes
•Sympathectomy to treat LQTS and CPVT – duration <15 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

Samuel J. Asirvatham, MD, FHRS
Mayo Clinic
Rochester, MN

William G. Stevenson, MD
Brigham and Women's Hospital
Boston, MA

Takumi Yamada, MD, PhD
University of Alabama at Birmingham
Birmingham, AL

Paolo Della Bella, MD
Ospedale San Raffaele
Milano, Italy

Saurabh Kumar, BSc(Med), MBBS
Brigham and Women's Hospital
Melbourne, MA

Koonlawee Nademanee, MD, FHRS, CCDS
Pacific Rim Electrophysiology Research Institute Center
Los Angeles, CA

J. David Burkhardt, MD, FHRS
Texas Cardiac Arrhythmia Institute
Austin, TX

Kyoko Soejima, MD
Kyorin University Hospital
Mitaka-City, Japan

Christopher Moir, MD
Mayo Clinic
Rochester, MN

 

Journal CME/HeartRhythm Journal: December 2016 Vol. 13, Issue 12: Entrainment of Ventricular Tachycardia: Is the Pacing Site In or Out?

  • Description
  • Faculty
  • CME Information

A 77-year-old man with history of ischemic cardiomyopathy with an ejection fraction of 35% was referred for ablation of recurrent VT.  Electroanatomic mapping of the epicardium revealed apical scar during RV pacing, with focal activation during VT, originating from the apex. Endocardial mapping confirmed the extensive dense scar extending from the base toward the apex along the anteroseptal wall.  Within the more apical portion of the scar, there was a localized region with late potentials and split electrograms.

The clinical VT was induced by endocardial pacing within the anteroseptal scar and was hemodynamically tolerated.  Overdrive pacing was performed to assess the response to entrainment with a multielectrode catheter that recorded local diastolic activity.  Is the pacing site in or out of the reentrant circuit?

Andrew Beaser, MD
Kelvin Chua, MD
Gaurav Upadhyay, MD
Roderick Tung, MD, FHRS

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™

S-ICD Device Therapy: Management and Patient Selection

  • Description
  • Presentations
  • Faculty

S-ICD Device Therapy:  Management and Patient Selection

This learning pathway will help with decision of choosing the right ICD for a patient - SICD or transvenous ICD.   

Participants will understand the benefits and limitations of S-ICDs. They will also learn practical tips and tricks for the management and troubleshooting of these devices.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations include:

  • What is the Optimal Single Chamber ICD System: Transvenous or Subcutaneous? – duration <45 minutes
  • S-ICD Versus a Transvenous ICD: Screening and Selection of Patients – duration <20 minutes
  • S-ICD versus Transvenous ICD: What You Need to Look for During Device Follow-up – duration <20 minutes
  • Single Chamber ICD Lead Fracture: New Transvenous Lead or New Subcutaneous ICD – duration <25 minutes
  • Impact of BMI on Safety and Efficacy of the Subcutaneous ICD – duration <15 minutes

Ronald D. Berger, MD, PhD, FHRS
Johns Hopkins University
Baltimore, MD

Reinoud E. Knops, MD, CCDS
Academic Medical Center
Amsterdam, Netherlands

Bradley P. Knight, MD, FHRS
Cooley Professor of Medicine
Director of Cardiac Electrophysiology Northwestern University

Carrie Brown, APN
Heart Rhythm Center
University of Chicago Medicine

Melanie Maytin, MD, FHRS
Brigham and Women's Hospital
Boston, MA

David S. Frankel, MD, FHRS
Hospital of the University of Pennsylvania
Philadelphia, PA

CRT for Atypical Populations

  • Description
  • Presentations
  • Faculty

CRT for Atypical Populations

As the tools to provide successful left ventricular lead placement have expanded, the appropriate patient population to benefit from cardiac resynchronization therapy is still unclear.  Is there a role for CRT in the patient with a non-left bundle branch block pattern, or for a narrow QRS? 

What are future advances?  Once a CRT device is implanted, this pathway will provide insights on how to avoid non-responders.  

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations include:

CRT in Octogenerians <20 minutes
CRT in Patients with Renal Dysfunction <20 minutes
CRT in Patients with RBBB <20 minutes
CRT Gender and Race Considerations <20 minutes

Debate - Is AV Node Ablation Necessary to Achieve Cardiac Resynchronization in AF Patients? <45 minutes

Cardiac resynchronization therapy in the elderly with or without an implantable defibrillator <20 minutes

Multiple comorbidities and response to CRT-D: Results from the MADIT-CRT long-term follow-up study <20 minutes

CRT for the Patient with a Narrow QRS <20 minutes

Challenges CRT Cases - My Patient has Pacing Induced CM. Should I Implant a CRT-D or CRT-P? <15 minutes
Challenges CRT Cases - My Patient With a PPM Needs an Upgrade to a BiV ICD Cap or Extract? <15 minutes

Sana M. Al-Khatib, MD, MHS, FHRS, CCDS
Duke University Medical Center
Durham, NC

Theofanie Mela, MD
Massachusetts General Hospital
Boston, MA

Maurizio Gasparini, MD
Humanitas Research Hospital
Rozzano-Milano, Italy

Uma N. Srivatsa, MD, FHRS
University of California - Davis Medical Center
Sacramento, CA

Michele Brignole, MD
Ospedali del Tigullio
Lavagna, Italy

Derek V. Exner, MD, MPH, FHRS
Libin Cardiovascular Institute of Alberta
Calgary, AB, Canada

Michael Doering, MD
University Leipzig, Heart Centre
Leipzig, Germany

Emily P. Zeitler, MD
Duke University Hospital
Durham, NC

Rupa Bala, MD
University of Pennsylvania
Philadelphia, PA

Sherry Saxonhouse, MD
Sanger Heart and Vascular Institute
Charlotte, NC

Charles A. Henrikson, MD, FHRS
Oregon Health and Science University, Knight Cardiovascular Institute
Portland, OR

Journal CME/HeartRhythm Journal: November 2016 Vol. 13, Issue 11: What is the Mechanism of Second Tachycardia?

  • Description
  • Faculty
  • CME Information

A 26-year-old female patient underwent an electrophysiology study for symptoms of recurrent palpitations and documented supraventricular tachycardia (SVT) on Holter monitoring. The electrophysiology study was performed with quadripolar catheters placed at the high right atrium, the right ventricle, and the His region and an octapolar catheter placed in the coronary sinus.

Dinesh Sharma, MD
Shigeki Kusa, MD
Srinivas Dukkipati, MD, FHRS
Vivek Y. Reddy, MD

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™.

Implantation Procedure for a Subcutaneous Implantable Cardiac Defibrillator (S-ICD)

  • Description
  • Faculty
  • CME Information

Description

This learning pathway discusses the pre-, intra-, and post- procedure care for the implantation of a subcutaneous implantable defibrillator (S-ICD).   This activity is complimentary.

The presentations are:

  • Pre-Procedure S-ICD Assessment – duration <6 minutes
  • S-ICD Implantation Techniques – duration <10 minutes
  • Live Case - Implantation of a S-ICD – duration <25 minutes
  • Successful Implantation of CIED Devices –
    - Ensuring an Adequate Defibrillation Threshold Following a Subcutaneous ICD Implant - duration <20 minutes 
    - CIED Implantation in a Patient on Anticoagulation - duration <20 minutes
  • Post-Procedure S-ICD Assessment – duration <5 minutes
  • Improving Efficacy - 
    -Impact of BMI on Safety and Efficacy of the Subcutaneous ICD - duration <20 minutes
    -Evaluation of a High Pass Filter Designed to Reduce Over-sensing in the S-ICD – duration <20 minutes
    -First Report On Communicating Leadless Anti-Tachycardia Pacemaker and Subcutaneous Implantable Defibrillator – duration <20 minutes
  • Novel Extravascular Defibrillation Configuration with a Coil in the Substernal Space - duration <20 minutes
  • Current Status of the S-ICD and Its Use in Pediatric Patients – duration 25 minutes

 

Raul Weiss, MD, FHRS, CCDS
Ohio State University Medical Center
Division of Cardiovascular Medicine

Emile Dauod, MD, FHRS
Professor of Internal Medicine
Ohio State University Medical Center
Division of Cardiovascular Medicine

Dan L. Musat, MD
Valley Health System
Ridgewood, NJ

David S. Frankel, MD, FHRS
Hospital of the University of Pennsylvania
Philadelphia, PA,

Dominic A. Theuns, PhD
Erasmus Medical Center
Rotterdam, Netherlands

Fleur V.y. Tjong, MD
Academic Medical Center
Amsterdam, Netherlands

Janice Till, MD
Royal Brompton Hospital
United Kingdom

Joseph YS Chan, MD
Prince of Wales Hospital
Hong Kong

No CME is available for this complimentary activity.

Optimal ICD Programming and Testing: Strategies and Highlights from the International Consensus Document

  • Description
  • Faculty
  • CME Information

The HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing contains 32 consensus recommendations developed by a writing group of international experts. Learn how to implement these recommendations in your clinical practice by viewing this activity, presented by the document Chairs.

Laurent Fauchier, MD, PhD

Carlos Morillo, MD, FRCPC, FHRS

David Slotwiner, MD, FHRS

Martin Stiles, MBCHB, PhD

Bruce Wilkoff, MD, FHRS, CCDS

No CME credit is attached to this activity.

Mapping and Ablation of Atrial Tachycardias and Atypical Flutters

  • Description
  • Faculty
  • CME Information

This learning pathway discusses the clinically relevant day-to-day challenges in mapping and ablation of atrial tachycardias and atypical flutters. Choose from multiple presentations that each focus on a different aspect and/or audience level of the topic via the HRS Learning Center.

Jonathan M. Kalman, MBBS, PhD, FHRS 
Royal Melbourne Hospital, Melbourne, Australia

Peter M. Kistler, MBBS, PhD
Alfred Hospital and Baker Heart and Diabetes Institute, Melbourne, Australia

Samuel J. Asirvatham, MD, FHRS
Mayo Clinic, Rochester, MN

Natasja De Groot, MD, PhD 
Erasmus Medical Center, Rotterdam, Netherlands

Edward P. Gerstenfeld, MD, FHRS
Cardiac Electrophysiology 
Univeristy of California, San Francisco

Fermin C.Garcia, MD
Hospital of the University of Pennsylvannie, Philadelphia, PA

Pierre Jais, MD 
Hôpital Haut-Lévêque, Bordeaux, France

Mark McGuire, MBBS, PhD 
Royal Prince Alfred Hospital, Sydney, Australia

CME/CE is NOT available for this activity

View All Activities